1Donati MB. Cancer and thrombosis [ J ]. Haemostasis, 1994, 24 : 128 - 131.
2Goldhaber SZ,Tapson VF. DVT FREE Steering Committee. A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis[ J]. Am J Cardiol,2004,93:259 - 262.
3Blom JW, Doggen C J, Osanto S, et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J]. JAMA,2005, 293:715 -722.
4Rickles FR, Levine MN. Venous thromboembolism in malignancy and malignancy in venous thromboembolism [ J ]. Haemostasis, 1998,28:43 - 49.
5Levine MN,Lee AY,Kakkar AK. Thrombosis and cancer[ J]. Am Soc Clin Oncol Educ Book ,2005:748.
6Gordon SG,Cross BA. An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as new tumor marker [ J ]. Cancer Res, 1990,50:6229 - 6234.
7Honn KV, Steinert BW, Moin K, et al. The role of platelet cyclooxygenase and lipoxygenase pathways in tumor cell induced platelet aggregation[ J]. Biochem Biophys Res Commun,1987 ,145 :384 - 389.
8Schreiber DP, Kapp DS. Axillary-subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma[ J]. lnt J Radiat Oncol Biol Phys, 1986,12:391 -395.
9Wilfried R, Herwig K, Christine H, et al. Prothrombin G20210A, Factor Ⅴ Leiden, and Factor ⅩⅢ Val34Leu : common mutations of blood coagulation factor and deep vein thrombosis in Austria[ J]. Throm Res ,2000,99:35 - 39.
